Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot study

BACKGROUND: To evaluate the association between the therapeutic outcomes of sorafenib for advanced hepatocellular carcinoma (HCC) and the parameters of intravoxel incoherent motion (IVIM). METHODS: Nine patients were evaluated prospectively. All patients were Child-Pugh score A. The mean dimension o...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirota, Natsuhiko, Saito, Kazuhiro, Sugimoto, Katsutoshi, Takara, Kenichi, Moriyasu, Fuminori, Tokuuye, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731920/
https://www.ncbi.nlm.nih.gov/pubmed/26822946
http://dx.doi.org/10.1186/s40644-016-0059-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731920/
https://www.ncbi.nlm.nih.gov/pubmed/26822946
http://dx.doi.org/10.1186/s40644-016-0059-3

Ejemplares similares